Susquehanna Fundamental Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$333K Buy
+15,456
New +$351K 0.01% 1220
2021
Q4
Sell
-20,829
Closed -$540K 1418
2021
Q3
$540K Sell
20,829
-30,200
-59% -$808K 0.01% 1166
2021
Q2
$1.38M Sell
51,029
-2,200
-4% -$53.7K 0.03% 727
2021
Q1
$1.25M Buy
53,229
+3,850
+8% +$77.8K 0.02% 802
2020
Q4
$757K Buy
49,379
+16,479
+50% +$209K 0.01% 962
2020
Q3
$397K Buy
32,900
+20,000
+155% +$190K 0.01% 966
2020
Q2
$131K Buy
+12,900
New +$133K 0.01% 883

Other funds holding ANGO

Susquehanna Fundamental Investments's ANGO Position: Q1 2022 in Review

Susquehanna Fundamental Investments opened a new position in AngioDynamics (ANGO) in Q1 2022: 15,456 shares worth $333K. The stake represents 0.01% of the portfolio and ranks #1220 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in ANGO as recently as Q3 2021.

Susquehanna Fundamental Investments first reported a position in ANGO in Q2 2020 and has held it in 7 quarters since. The position peaked at $1.38M in Q2 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

  • Susquehanna Fundamental Investments held 15,456 shares of AngioDynamics worth $333K as of Q1 2022.
  • AngioDynamics was a new Susquehanna Fundamental Investments position in Q1 2022.
  • AngioDynamics made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1220 holding.
  • Susquehanna Fundamental Investments first reported a position in AngioDynamics in Q2 2020 and has held it in 7 quarters since.
  • Susquehanna Fundamental Investments's AngioDynamics position peaked at $1.38M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.